TABLE 2.
Primer designation | Nucleotide sequencea | Genome location | Orientation | Purpose |
---|---|---|---|---|
PmeI | ||||
MHV A 5′ 17(+) | 5′-NGTTTAAACNNNNNNTAATACGACTCACTATAGATAAGAGTGATTGGCGTCCG-3′ | 1-21 | + | T7 start |
CC | ||||
MHV A 3520-mu(+) | 5′-TAAAGTGGGTTTCATCACTCGGCAC-3′ | 3528-3506 | − | Overlapping PCR Esp3I mutagenesis |
GG | ||||
MHV A 3520-mu(−) | 5′-GCCGAGTGATGAAACCCACTTTAAAGTG-3′ | 3506-3533 | + | Overlapping PCR Esp3I mutagenesis |
Esp3IGA | ||||
MHV A 4870(−) | 5′-CGTCTCATTTGTTAACCAGTCGCCAGTCTGTGGGCAG-3′ | 4887-4856 | − | MHV A/B junction |
MHV B 4870(+) | 5′-CGTCTCACAAATTTGATAGTGTTGATGGTG-3′ | 4888-4905 | + | MHV A/B junction |
MHV B 9620(−) | 5′-ACTGAACTCGCCGTTAAGGC-3′ | 9571-9552 | − | MHV B/C junction |
T | ||||
MHV C 8933(+) | 5′-GGTATAGTCTACATTTGGTC-3′ | 8932-8952 | + | MHV B/C junction |
MHV C 11511(−) | 5′-CGTCTCTGGTTTATGCTACGCATGGTAAC-3′ | 11515-11493 | − | MHV C/D junction |
MHV D 11511(+) | 5′-CGTCTCAAACCACGACGTCTTTTCTATTATG-3′ | 11510-11534 | + | MHV C/D junction |
MHV D 12960(−) | 5′-CGTCTCTTAGGATAGCATACACAATCTTACCC-3′ | 12966-12941 | − | MHV D/E junction |
AT | ||||
MHV E 12960(+) | 5′-CGTCTCTCCTAAGTGACTGTGATGGTCTCAAG-3′ | 12961-12986 | + | MHV D/E junction |
MHV E 15760(−) | 5′-CGTCTCTAGACATTAGAGTATAGGCGC-3′ | 15759-15739 | − | MHV E/F junction |
MHV F 15760(+) | 5′-CGTCTCTGTCTATCGTGCGGACCATGTTG-3′ | 15754-15776 | + | MHV E/F junction |
CC | ||||
MHV F 17135-mu(−) | 5′-TATTCTGAAAGGTTTCAGGCACACTATAAACAC-3′ | 17150-17118 | − | Overlapping PCR Esp3I mutagenesis |
GG | ||||
MHV F 17135-mu(+) | 5′-GTGCCTGAAACCTTTCAGAATAATGTGCC-3′ | 17129-17157 | + | Overlapping PCR Esp3I mutagenesis |
AA | ||||
MHV F 22740(−) | 5′-CGTCTCTCGGACCGACTGTCACCAAATAGAAACC-3′ | 22744-22717 | − | MHV F/G junction |
Esp3ITT | ||||
MHV G 22760(+) | 5′-(N)6CCCGGGCGTCTCGTCCGACTGTACCTATGTAG-3′ | + | MHV F/G junction | |
MHV G 24031(−) | 5′-AACGGTCTCAGTGCTAATGCTTGG-3′ | 24054-24031 | − | MHV G end |
Underlined sequences represent the T7 start site, and boldface sequences represent the Esp3I or PmeI restriction sites. All primers were derived from the MHV-A59 sequence (30).